Technical Analysis for 0RDU - Grifols, S.A

Grade Last Price % Change Price Change
F 7.45 -1.38% -0.10
0RDU closed down 1.38 percent on Monday, March 18, 2024, on 2 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -1.38%
Gapped Up Strength -1.38%
Wide Bands Range Expansion 4.50%
Down 3 Days in a Row Weakness 4.50%
Boomer Sell Setup Bearish Swing Setup -5.94%
NR7 Range Contraction -5.94%
Narrow Range Bar Range Contraction -5.94%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Grifols, S.A Description

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum"from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring"to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.


Classification

Is 0RDU a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.6675
52 Week Low 6.366
Average Volume 84,159
200-Day Moving Average 11.34
50-Day Moving Average 9.87
20-Day Moving Average 9.02
10-Day Moving Average 7.64
Average True Range 0.94
RSI (14) 39.76
ADX 34.4
+DI 13.88
-DI 32.96
Chandelier Exit (Long, 3 ATRs) 9.02
Chandelier Exit (Short, 3 ATRs) 9.18
Upper Bollinger Bands 12.61
Lower Bollinger Band 5.43
Percent B (%b) 0.28
BandWidth 79.61
MACD Line -0.83
MACD Signal Line -0.73
MACD Histogram -0.0905
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.36
Resistance 3 (R3) 8.46 8.26 8.21
Resistance 2 (R2) 8.26 8.03 8.21 8.16
Resistance 1 (R1) 7.86 7.89 7.76 7.76 8.11
Pivot Point 7.66 7.66 7.60 7.60 7.66
Support 1 (S1) 7.25 7.42 7.15 7.15 6.80
Support 2 (S2) 7.05 7.28 7.00 6.75
Support 3 (S3) 6.65 7.05 6.70
Support 4 (S4) 6.54